Management of polycythemia vera and essential thrombocythemia.

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn , Issue , 2005, Pages 201-208

  Campbell, Peter J ^a   Green, Anthony R ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

JAK2 PROTEIN, HUMAN; JANUS KINASE 2;

AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL TRIAL (TOPIC); DIFFERENTIAL DIAGNOSIS; GENETICS; HUMAN; MULTIMODALITY CANCER THERAPY; MUTATION; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA VERA; POLYMERASE CHAIN REACTION; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); THROMBOCYTHEMIA;

AMINO ACID SUBSTITUTION; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; HUMANS; JANUS KINASE 2; MUTATION; MYELOPROLIFERATIVE DISORDERS; POLYCYTHEMIA VERA; POLYMERASE CHAIN REACTION; PREVALENCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THROMBOCYTHEMIA, ESSENTIAL;

EID: 79959322566     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation-2005.1.201     Document Type: Article

References (0)